Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban ...
Source: [Guardian World](https://www.theguardian.com/us-news/2026/oct/13/martin-shkreli-ftc-ruling-pharma-ban)